Orange County Research Center

Lake Forest, California 92630

13 studies enrolling now · 42 studies all time

What they study most

Adhesive Wear Time, Asthma, Atherosclerotic Cardiovascular Disease, COVID-19, COVID-19 (Coronavirus Disease 2019), Cardiometabolic Disease, Cardiovascular Diseases, Chronic Kidney Disease, Diabetes Mellitus, Type 2, Difficult to Control Hypertension, Healthy, Healthy Participants

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib — Recruiting now
• A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus — Recruiting now
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function — Recruiting now
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Recruiting now
• Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) — Recruiting now
• A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function — Recruiting now
• A Study to Learn About a Vaccine Against E Coli in Healthy Adults — Recruiting now
• Gen 2 Battrode Wear Study — Recruiting now
• To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension — Recruiting now
• A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity — Completed
• A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity — Starting soon
• A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Running, not enrolling
• A Study to Learn About How a New Pneumococcal Vaccine Works in Adults — Running, not enrolling
• A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma — Running, not enrolling
• A Study About Modified RNA Vaccines Against Influenza in Healthy Adults — Completed
• An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver Damage — Completed
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants — Stopped early
• A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL) — Completed
• A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the Body — Completed
• Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function — Completed
• A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People — Completed
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. — Completed
• A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling
• Mobile Cardiac Telemetry (MCT) Study — Completed
• A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults — Completed
• A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes — Withdrawn before enrolling
• A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants — Completed
• A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People — Completed
• A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease — Completed
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza — Completed
• A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People — Completed
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
• A Study to Learn About Study Medicine Called PF-07261271 in Healthy People — Completed
• A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers — Completed
• A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function — Completed
• A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function — Completed
• A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV). — Completed
• Study of GBT021601 in Participants With Renal Impairment — Stopped early